Pre-clinical study of protective potency of candidate recombinant live pertussis vaccine for intranasal administration
The aim of present research is studying of protective potency of candidate recombinant live pertussis vaccine (RLPV) for intranasal administration.Materials and methods. Two methods of protective potency assessment, based on mice survival estimating, were used: after intracerebral administration of...
Main Authors: | L. N. Sinyashina, E. G. Semin, A. Yu. Medkova, R. A. Syundyukova, G. I. Karataev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Central Research Institute for Epidemiology
2019-08-01
|
Series: | Журнал микробиологии, эпидемиологии и иммунобиологии |
Subjects: | |
Online Access: | https://microbiol.elpub.ru/jour/article/view/365 |
Similar Items
-
Pre-Clinical Toxicity Study and Safety Assessment of Candidate Live Pertussis Vaccine for Intranasal Administration
by: L. N. Sinyashina, et al.
Published: (2019-01-01) -
Safety and immunogenicity of live intranasal pertussis vaccine GamLVP in the experimental infant hamadryas baboon model
by: A. A. Djidaryan, et al.
Published: (2022-05-01) -
Immunogenicity of GamLPV, an intranasal live vaccine for pertussis prevention, in adult volunteers: a blind, randomised, placebo-controlled trial to optimise the method and schedule of administration
by: A. A. Lidzhieva, et al.
Published: (2022-03-01) -
Safety, immunogenicity, and protective efficacy of the intranasal live pertussis vaccine GamLPV in an infant monkey model (<i>Papio hamadryas</i>)
by: D. T. Kubrava, et al.
Published: (2024-12-01) -
Immunogenicity of the drug "Live intranasal vaccine for the prevention of pertussis" (GamLPV) with a single use in healthy volunteers
by: A. Yu. Medkova, et al.
Published: (2022-01-01)